Graduate Programs in the Biomedical Sciences

Lab Supplies

Toby Tucker Hecht, Ph.D.


Deputy Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH

Ph.D. 1973 (Microbiology and Immunology), Albert Einstein College of Medicine of Yeshiva University

Mentor: Dr. Donald F. Summers (Microbiology & Immunology)

Dr. Hecht has worked for over 35 years at the NIH, 27 of which have been at the NCI. Leading teams of scientists and other professionals, Dr. Hecht has been responsible for the bench-to-bedside development of numerous agents such as dinutuximab, a monoclonal antibody that is now an effective new treatment for children with high-risk neuroblastoma, the most common form of cancer in infants. She has also led the NCI’s SPORES (Specialized Programs of Research Excellence) program which facilitates organ-site-based, multidisciplinary translational research at 51 sites among 27 institutions across the country. In addition, she has had an instrumental role in the NCI Provocative Question Initiative, in which scientists are encouraged to think “outside the box” for answers to perplexing questions in cancer research.

NIH Merit Award- 2002, 2011 and 2012

Click here to log in
height: 340px !important; background-image: url(/images/education/phd/bg/bg-apply-xxl.png);